Related Experiment Video

Updated: Jun 21, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

To kill tumor cells or permanently paralyze them in senescence?

K Christov1

  • 1Department of Surgical Oncology and Cancer Center, University of Illinois at Chicago, Chicago, IL 60612, USA. christov@uic.edu

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|August 4, 2009
PubMed

Insights

Retinoids can induce cellular senescence (CS) in breast cancer cells, halting tumor growth. The retinoic acid receptor beta 5 (RARbeta5) plays a key role in this process, offering potential clinical applications.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Antitumor agents employ four main mechanisms: inhibiting proliferation, inducing differentiation, cell death, or senescence.
  • Cellular senescence (CS) involves permanent cell cycle arrest, preventing tumor cell division, invasion, metastasis, and treatment resistance.

Purpose of the Study:

  • To review the role of retinoids in inducing cellular senescence in mammary pre-malignant and tumor cells.
  • To highlight the specific involvement of retinoic acid receptor beta 5 (RARbeta5) in mediating retinoid-induced senescence.
  • To discuss the potential clinical implications of retinoid-induced senescence in breast cancer therapy.

Main Methods:

  • Literature review focusing on studies investigating retinoid effects on mammary cells.
  • Analysis of research detailing the mechanisms of retinoid-induced cellular senescence.
  • Examination of the role of retinoic acid receptor beta 5 (RARbeta5) in senescence pathways.

Main Results:

  • Retinoids effectively induce cellular senescence in various pre-malignant and tumor mammary cell lines.
  • Retinoic acid receptor beta 5 (RARbeta5) is identified as a critical mediator of the retinoid-induced senescent program.
  • Senescent cells generated by retinoids exhibit suppressed proliferation and invasiveness.

Conclusions:

  • Retinoid-induced cellular senescence represents a promising strategy for inhibiting breast cancer progression.
  • Targeting RARbeta5 may enhance the efficacy of retinoid-based cancer therapies.
  • Further clinical investigation is warranted to explore the therapeutic potential of this approach.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.